Related Experiment Video

Updated: Aug 12, 2026

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

A variant form of ETS1 induces apoptosis in human colon cancer cells

C C Huang1, T S Papas, N K Bhat

  • 1Center for Molecular and Structural Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston 29425, USA.

Oncogene
|August 14, 1997
PubMed

Insights

The ETS1 protein variant p42-ETS1 reduces colon cancer tumor growth by inducing apoptosis. This finding offers potential new gene therapy strategies for epithelial cell cancers.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The ETS1 protein (p51-ETS1) has been shown to reduce colon cancer tumorigenicity without impacting cell growth.
  • Understanding the precise mechanisms behind tumor reduction is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the differential effects of ETS1 protein variants on colon cancer cell tumorigenicity.
  • To elucidate the mechanism by which the p42-ETS1 variant represses tumor growth.

Main Methods:

  • Ectopic expression of two ETS1 protein forms (p51-ETS1 and p42-ETS1) in colon cancer cell lines.
  • Analysis of tumorigenicity and growth properties of engineered cell lines.
  • Investigation of apoptosis induction by the p42-ETS1 variant.

Main Results:

  • Both p51-ETS1 and the spliced variant p42-ETS1 reduced colon cancer cell tumorigenicity.
  • The p42-ETS1 variant, lacking ETS1 exon VII, specifically repressed tumorigenicity.
  • p42-ETS1-mediated repression of tumorigenicity was linked to its ability to induce apoptosis in cancer cells.

Conclusions:

  • The p42-ETS1 variant plays a significant role in repressing colon cancer cell tumorigenicity, primarily through the induction of apoptosis.
  • These findings highlight the potential of p42-ETS1 in gene therapy for epithelial cell cancers by initiating cancer cell death.

More Related Videos

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

Using the E1A Minigene Tool to Study mRNA Splicing Changes10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...